{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:30:38Z","timestamp":1752550238331},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s11596-014-1255-7","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T04:20:55Z","timestamp":1396844455000},"page":"181-185","source":"Crossref","is-referenced-by-count":8,"title":["Expression of cancer-testis antigen in multiple myeloma"],"prefix":"10.1007","volume":"34","author":[{"given":"Li","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-na","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Er","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,8]]},"reference":[{"issue":"18","key":"1255_CR1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med, 2004,351(18):1860\u20131873","journal-title":"N Engl J Med"},{"issue":"1","key":"1255_CR2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajh.22237","volume":"87","author":"SV Rajkumar","year":"2012","unstructured":"Rajkumar SV. Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management. Am J Hematol, 2012,87(1):78\u201388","journal-title":"Am J Hematol"},{"issue":"2","key":"1255_CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/RCT.0b013e318245c261","volume":"36","author":"S Philips","year":"2012","unstructured":"Philips S, Menias C, Vikram R, et al. Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum. J Comput Assist Tomogr, 2012,36(2): 207\u2013212","journal-title":"J Comput Assist Tomogr"},{"key":"1255_CR4","first-page":"12","volume":"6","author":"HJ Cho","year":"2006","unstructured":"Cho HJ, Caballero OL, Gnjatic S, et al. Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NYESO-1 (CT6). Cancer Immun, 2006,6:12","journal-title":"Cancer Immun"},{"issue":"11","key":"1255_CR5","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/jcb.23252","volume":"112","author":"K Rajagopalan","year":"2011","unstructured":"Rajagopalan K, Mooney SM, Parekh N, et al. A majority of the cancer\/testis antigens are intrinsically disordered proteins. J Cell Biochem, 2011,112(11):3256\u20133267","journal-title":"J Cell Biochem"},{"issue":"9","key":"1255_CR6","doi-asserted-by":"crossref","first-page":"e12773","DOI":"10.1371\/journal.pone.0012773","volume":"5","author":"OL Caballero","year":"2010","unstructured":"Caballero OL, Zhao Q, Rimoldi D, et al. Frequent MAGE mutations in human melanoma. PLoS One, 2010,5(9): e12773","journal-title":"PLoS One"},{"issue":"6","key":"1255_CR7","doi-asserted-by":"crossref","first-page":"e21418","DOI":"10.1371\/journal.pone.0021418","volume":"6","author":"A Curioni-Fontecedro","year":"2011","unstructured":"Curioni-Fontecedro A, Nuber N, Mihic-Probst D, et al. Expression of MAGE-C1\/CT7 and MAGE-C2\/CT10 predicts lymph node metastasis in melanoma patients. PLoS One, 2011,6(6):e21418.","journal-title":"PLoS One"},{"issue":"3","key":"1255_CR8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1634\/stemcells.2006-0469","volume":"25","author":"FF Costa","year":"2007","unstructured":"Costa FF, Blanc KL, Brodin B. Concise review: cancer\/testis antigens, stem cells, and cancer. Stem Cells, 2007,25(3):707\u2013711","journal-title":"Stem Cells"},{"issue":"1","key":"1255_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2004-12-4931","volume":"106","author":"AA Jungbluth","year":"2005","unstructured":"Jungbluth AA, Ely S, Diliberto M, et al. The cancer-testis antigens CT7 (MAGEC1) and MAGE-A3\/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. Blood, 2005,106(1):167\u2013174","journal-title":"Blood"},{"issue":"11","key":"1255_CR10","doi-asserted-by":"crossref","first-page":"e27707","DOI":"10.1371\/journal.pone.0027707","volume":"6","author":"F Carvalho de","year":"2011","unstructured":"de Carvalho F, Costa ET, Camargo AA, et al. Targeting MAGE-C1\/CT7 expression increases cells sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines. PLoS One, 2011,6(11):e27707","journal-title":"PLoS One"},{"issue":"5","key":"1255_CR11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3324\/haematol.2009.014464","volume":"95","author":"D Atanackovic","year":"2010","unstructured":"Atanackovic D, Hildebrandt Y, Jadczak A, et al. Cancer-testis antigens MAGE-C1\/CT7 and MAGE-A3 promote the survival of multiple myeloma cells. Haematologica, 2010,95(5):785\u2013793","journal-title":"Haematologica"},{"issue":"4","key":"1255_CR12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/1078-0432.CCR-08-0989","volume":"15","author":"D Atanackovic","year":"2009","unstructured":"Atanackovic D, Luetkens T, Hildebrandt Y, et al. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma. Clin Cancer Res, 2009,15(4):1343\u20131352","journal-title":"Clin Cancer Res"},{"key":"1255_CR13","doi-asserted-by":"crossref","first-page":"150 591","DOI":"10.1155\/2010\/150591","volume":"2010","author":"HA Smith","year":"2010","unstructured":"Smith HA, McNeel DG. The SSX family of cancer-test is antigens as target proteins for tumor therapy. Clin Dev Immunol, 2010,2010:150 591","journal-title":"Clin Dev Immunol"},{"issue":"6","key":"1255_CR14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.cji.0000175685.36239.e5","volume":"28","author":"BJ Taylor","year":"2005","unstructured":"Taylor BJ, Reiman T, Pittman JA, et al. SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs. J Immunother, 2005,28(6):564\u2013575","journal-title":"J Immunother"},{"key":"1255_CR15","first-page":"257 695","volume":"2012","author":"F Carvalho de","year":"2012","unstructured":"de Carvalho F, Vettore AL, Colleoni GW. Cancer\/testis antigen MAGE-C1\/CT7: new target for multiple myeloma therapy. Clin Dev Immunol, 2012,2012:257 695","journal-title":"Clin Dev Immunol"},{"key":"1255_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2407-13-144","volume":"13","author":"R Kim","year":"2013","unstructured":"Kim R, Kulkarni P, Hannenhalli S. Derepression of cancer\/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation. BMC Cancer, 2013,13:144","journal-title":"BMC Cancer"},{"key":"1255_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1479-5876-11-123","volume":"11","author":"T Hudolin","year":"2013","unstructured":"Hudolin T, Kastelan Z, Ilic I, et al. Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer\/testis antigens in diffuse large B-cell testicular lymphoma. J Transl Med, 2013,11:123","journal-title":"J Transl Med"},{"issue":"5038","key":"1255_CR18","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","volume":"254","author":"P Bruggen van der","year":"1991","unstructured":"van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized bycytolytic T lymphocytes on a human melanoma. Science, 1991,254(5038): 1643\u20131647","journal-title":"Science"},{"issue":"1","key":"1255_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00262-012-1376-4","volume":"62","author":"F Carvalho de","year":"2013","unstructured":"de Carvalho F, Alves VL, Braga WM, et al. MAGE-C1\/CT7 and MAGE-C2\/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy. Cancer Immunol Immunother, 2013,62(1):191\u2013195","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"1255_CR20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/1078-0432.CCR-08-0989","volume":"15","author":"D Atanackovic","year":"2009","unstructured":"Atanackovic D, Luetkens T, Hildebrandt Y, et al. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma. Clin Cancer Res, 2009,15(4):1343\u20131352","journal-title":"Clin Cancer Res"},{"key":"1255_CR21","first-page":"2","volume":"8","author":"VC Andrade","year":"2008","unstructured":"Andrade VC, Vettore AL, Felix RS, et al. Prognostic impact of cancer\/testis antigen expression in advanced stage multiple myeloma patients. Cancer Immun, 2008,8:2","journal-title":"Cancer Immun"},{"issue":"2","key":"1255_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1525-1578(10)60545-4","volume":"7","author":"N Naka","year":"2005","unstructured":"Naka N, Joyama S, Tsukamoto Y, et al. Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification. J Mol Diagn, 2005,7(2):187\u2013197","journal-title":"J Mol Diagn"},{"issue":"10","key":"1255_CR23","first-page":"2839","volume":"5","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Bao L, Chen H, et al. Expression level of MAGE-C1\/CT7 gene in bone marrow cells with multiple myeloma by real-time quantitative PCR. Ch Chin J Clin (Chinese), 2011,5(10):2839\u201328","journal-title":"Ch Chin J Clin (Chinese)"},{"issue":"5","key":"1255_CR24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2217\/fon.10.36","volume":"6","author":"SN Akers","year":"2010","unstructured":"Akers SN, Odunsi K, Karpf AR. Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy. Future Oncol, 2010,6(5):717\u2013732","journal-title":"Future Oncol"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1255-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-014-1255-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1255-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T08:43:44Z","timestamp":1565340224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-014-1255-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1255"],"URL":"https:\/\/doi.org\/10.1007\/s11596-014-1255-7","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}